Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Elena Rocca"'
Publikováno v:
Critical Public Health, Vol 34, Iss 1, Pp 1-9 (2024)
This paper discusses the issue of overriding the right of individual consent to participation in cluster randomised trials (CRTs). We focus on CRTs testing the efficacy of non-pharmaceutical interventions. As an example, we consider school closures d
Externí odkaz:
https://doaj.org/article/d5a8ff1afc414b54b9e6bad28cd2adb3
Autor:
Daniela Ragancokova, Elena Rocca, Anne M.M. Oonk, Herbert Schulz, Elvira Rohde, Jan Bednarsch, Ilse Feenstra, Ronald J.E. Pennings, Hagen Wende, Alistair N. Garratt
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 16 (2022)
Externí odkaz:
https://doaj.org/article/4d1c5e977068431cbbc61bd827f4e496
Publikováno v:
eLife, Vol 8 (2019)
Scientists seek to eliminate all forms of bias from their research. However, all scientists also make assumptions of a non-empirical nature about topics such as causality, determinism and reductionism when conducting research. Here, we argue that sin
Externí odkaz:
https://doaj.org/article/d0518d7089ba4f329d1def8648f0ab3b
This open access book is a unique resource for health professionals who are interested in understanding the philosophical foundations of their daily practice. It provides tools for untangling the motivations and rationality behind the way medicine an
Autor:
Elena Rocca, Saúl Pérez‐González
Publikováno v:
Journal of Evaluation in Clinical Practice.
Publikováno v:
STUDI ORGANIZZATIVI. :50-82
The present article shall analyse how organizations can activate stakeholder participation processes. Specifically, this article examines select participatory projects that were identified, developed and implemented within a network of Italian social
Publikováno v:
Drug Safety
Introduction The safety profile of remdesivir, conditionally approved for COVID-19, was limited at its 2020 introduction. Adverse drug reactions (ADRs) for medicines are collected in VigiBase, the WHO Global Database of Individual Case Safety Reports
Publikováno v:
Pharmaceutical Medicine
153–161
153–161
A new approach is proposed for assessing causality in pharmacovigilance. The Dx3 approach is designed to qualitatively evaluate three types of dispositions when assessing whether a particular medicine has or could have caused a certain adverse event.
Autor:
Saúl Pérez-González, Elena Rocca
Publikováno v:
Perspectives in biology and medicine
Traditionally, the understanding of biological mechanisms has played a central role in clinical reasoning. With the rise of the evidence-based paradigm, however, this role has come under scrutiny. On the one hand, clinical guidelines now place less e
Erice Call for Change: Utilising Patient Experiences to Enhance the Quality and Safety of Healthcare
Autor:
Rani Lill Anjum, Elena Rocca
Publikováno v:
Drug Safety
This ‘Erice Call for Change’ is a report from a group of experts, patients and patient representatives who met in Erice in September 2019 following previous similar meetings after the original Erice Declaration (1996). The aim of the meeting was